reSee.it Video Transcript AI Summary
The speaker argues that an irrational, unbridled enthusiasm for new possibilities leads to a sacrifice of safety. This enthusiasm, in their view, has adversely affected precautionary considerations and risk assessment. They reference presenting autopsy findings related to deaths following COVID-19 vaccination at the American Society of Microbiology, an event attended by thousands of microbiologists, vaccinologists, and immunologists. In conversations with attendees, the speaker was surprised by what they describe as a scientific seduction surrounding messenger RNA technology. The core concern expressed is that this eagerness to embrace mRNA platforms is accompanied by a neglect of safety considerations.
The speaker asserts that there will be a cataclysmic recognition that messenger RNA technology represents an unsafe platform. They emphasize that, as they understand it, there is no way to break down certain aspects of the technology they refer to as “pseudourogenated messenger RNA,” noting this within the context of their work in research laboratories. The statement implies a belief that the degradation or metabolic processing of this form of RNA poses unresolved issues.
A central, striking claim presented is that circulating messenger RNA from Pfizer or Moderna has been found in their patients’ bloodstream three years after vaccination, and that this RNA is intact. The speaker underscores this as evidence tied to their observations and research experiences, asserting the persistence of the RNA in the circulatory system over an extended period.
Overall, the message conveys a perspective that rapid adoption and optimism around mRNA vaccines and technologies have overshadowed safety considerations, and it anticipates a future realization of safety concerns associated with these platforms. The speaker ties their warnings to concrete experiences at a major scientific conference and to specific, long-term biomarkers observed in patients, presenting a narrative of ongoing research findings and anticipated paradigm shifts in how the safety of mRNA vaccines is perceived.